PlaqueTec
Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.
About
PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.
Technology stack
detected 2026-06-11Est. monthly stack spend~$170/mo
Email
Microsoft 365
Stack
Wix
Observability
Sentry
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does PlaqueTec do?
PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.
How much funding has PlaqueTec raised?
PlaqueTec has raised a total of $5M in funding. The most recent round on record is Funding Round.
Where is PlaqueTec headquartered?
PlaqueTec is headquartered in Cambridge, England, United Kingdom.
What industry does PlaqueTec operate in?
PlaqueTec operates in Biotechnology, Medical Devices, HealthTech, Artificial Intelligence.